The court is still scheduled to hear three other bellwether cases about the issue, with the next trial slated to begin in ...

In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Abbott Laboratories (NYSE:ABT). Abbott Laboratories (NYSE:ABT) is a leading manufacturer of health ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott ...

Abbott Laboratories (NYSE:ABT) announced strong profits, but the stock was stagnant. We did some digging, and we found some concerning factors in the details. Our free stock report includes 1 ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best medical device stocks to buy now. On April 16, CNBC reported that Trump’s tariffs ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., Abbott Laboratories and Linde plc, as well as a micro-cap stock Tredegar Corp.. The Zacks microcap ...

Abbott Laboratories (NYSE:ABT) develops and sells a diverse range of healthcare products including medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals.

Meta has appointed Robert Fergus, formerly a research director at Google DeepMind, to lead its Fundamental AI Research (FAIR) lab. Fergus, who co-founded FAIR in 2014, succeeds Joelle Pineau.

Meta Platforms Inc. told staff that it’s chosen Robert Fergus to helm its artificial intelligence research lab, elevating an employee who helped start the lab before a stint at competitor ...